Australia-based Propanc Biopharma announced it secured up to $100 million in funding from Hexstone Capital to build a crypto treasury and accelerate development of its lead cancer therapy PRP, which targets metastatic solid tumors. The private placement, structured as convertible preferred stock, includes an initial $1 million with up to $99 million available over the next 12 months.

South Korean retail investors have poured $6 billion into Ethereum treasury companies like BitMine and SharpLink, mirroring MicroStrategy's Bitcoin strategy. But critics warn this ETH accumulation boom is driven by influencer marketing rather than fundamentals. With Ethereum underperforming Bitcoin since 2022 and Korean capital heavily concentrated, the risks are mounting. Discover why Samson Mow says "this won't end well" and what the Kimchi Premium reveals about global cryp